p=0.859, p=0.379). Ayrıca Grup 2’ nin PEF ortalaması Grup 3’ e göre istatiksel olarak anlamlı düşük bulunmuş (p<0.01), Grup 4’ e göre değişmemiştir (p=0.065).
8. KAYNAKLAR
1. Dizdar EA, Tuncer A. The acute asthma treatment in children. Türkiye Klinikleri J Pediatr Sci 2007;3(9):38-45.
2. Adkinson NF, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FER. Middleton’s Allergy Principles and Practice, 6th Edition. Mosby, Philadelphia 2003. 3. Tattersfied AE, Knox AJ, Britton JR, Hall IP. Asthma. Lancet 2002;360(9342): 1313–22.
4. Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, Mitchell EA, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995;8(3):483–91.
5. Burney PJ, Chinn S, Rona J. Has the prevalence of asthma increased in children? Evidence from the national study of health and growth 1973–1986. Br Med J 1990; 300:1306–10.
6. Burr MR, Butland BK, King S, Vaughan-Williams E. Changes in asthma prevalence: Two surveys 15 years apart. Arch Dis Child 1989;64:1452–6.
7. Global Initiative for Asthma. Global strategy for asthma management and prevention revised 2006. Medical Communications Resources, NIH publication 2006.
8.Story RE. Asthma and obesity in children. Curr Opin Pediatr 2007;19:680-4. 9. Leung TF, Li CY, Lam CW, et al. The relation between obesity and asthmatic airway inflammation. Pediatr Allergy Immunol 2004;15:344-350.
10. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38.
11. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C- eactive protein levels in overweight and obese adults. JAMA 1999;282:2131-5. 12. Lavoie, K. L., Bacon, S. L., Labrecque, M. Higher BMI Is Associated With Worse Wsthma Control And Quality Of Life But Not Asthma Severity. Respir Med 2006;100: 648-657.
13. Gill, M., Graff, G. R., Adler, A. J., Dweik, R. A. Validation Study Of Fractional Exhaled Nitric Oxide Measurements Using A Handheld Monitoring Device. J Asthma. 2006;43:731-734.
14. Taylor, D. R. Nitric Oxide As A Clinical Guide For Asthma Management. J Allergy Clin Immunol. 2006;117:259-262.
15. Nadel JA, Busse WW. Asthma. Am J Respir Crit Care Med 1998;157:130–8. 16.Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: Executive summary of the GINA Dissemination Committee report. Allergy 2004;59(5):469-78. 17. Beasley R. The global burden of Asthma Report, Global Initiative for Asthma (GINA) 2004.
18. Bjorksten B, Dumitrascu D, Foucard T, Khetsuriani N, Khaitov R, et al. Prevalence of childhood asthma, rhinitis and eczema in Scandinavia and Eastern Europe. Eur Respir J 1998;12(2):432–7.
19. Weinberg EG. Urbanization and childhood asthma: an African perspective. J Allergy Clin Immunol 2000;105(2Pt 1):224–31.
20. Yan DC, Ou LS, Tsai TL, Wu WF, Huang JL. Prevelance and severity of symptoms of asthma, rhinitis, and eczema in 13- to 14-year-old children in Taipei, Taiwan. Ann Allergy Asthma Immunol 2005;95(6):579-85.
21. Carvajal-Uruena I, Garcia-Marcos L, Busquets-Monge R, Morales Suarez- Varela M, Garcia de Andoin N, Batlles-Garrido J, Blanco-Quiros A, Lopez- Silvarrey A, Garcia-Hernandez G, Guillen-Grima F, Gonzalez-Diaz C, Bellido- Blasco J. Geographic Variation in the Prevalence of Asthma Symptoms in Spanish Children and Adolescents. International Study of Asthma and Allergies in Childhood (ISAAC) Phase 3,Spain. Arch Broncopneumol 2005;41(12):659-66.
22. Teeratakulpisarn J, Wiangnon S, Kosalaraksa P, Heng S. Surveying the prevalence of asthma, allergic rhinitis and eczema in schoolchildren in Khon Kaen, Northeastern Thailand using the ISAAC questionnaire: Phase III. Asian Pac J Allergy Immunol 2004;22(4):175-81.
23. Garcia-Marcos L, Quiros AB, Hernandez, GG, Guillen-Grima F, Diaz CG, Urena IC, Pena AA, Monge RB, Suarez-Varela MM; Varela ALS, Cabanillas PG, Garrido JB. Stabilization of asthma prevalence among adolescents and increase among school children (ISAAC phases I and III) in Spain. Allergy 2004; 59(12):1301-1307.
24. International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjuntivitis and atopic eczema: ISAAC. Lancet 1998;351:1232–55.
25. Gibson PG, Wlodarczyk JW, Hensley MJ, et al. Epidemiological association of airway inflammation with asthma symptoms and airway hyperresponsiveness in childhood. Am J Respir Crit Care Med 1998;158:36-41.
26.Ones U, Akçay A, Tamay Z, Güler N, Zincir M. Rising trend of asthma prevalence among Turkish schoolchildren (ISAAC phases I and III). Allergy 2006;61:1448-53.
27. Türktaş İ, Selçuk ZT, Kalyoncu AF, et al. Prevelance of asthma and wheezing inTurkish Children. World Asthma Meeting, Barselona, İspanya. Eur Respir J 1998;12(Suppl 29):525.
28. Kalyoncu AF. Epidemiyoloji. In: Kalyoncu AF ve Türktaş H eds. Ulusal verilerle astma. Kent Matbaası, Ankara 1999:8-38
29. Demir E, Tanaç R, Can D, Gülen E, Yenigün A. Is there an increase in the prevelance of allergic diseases among school children from the Aegen region of Turkey? Allergy and Astma Proceedings 2005;26(5):410-414.
30. Mos HM, Gern JE, Lemanske RF Jr. Asthma in infancy and childhood. In: Atkinson FN, Yunginger JW, Busse WW, Bochner BS, Holgate St, Simsons FER (eds.). Allergy, Principles & Practice, 6th edition. Mosby-Year Book Inc, St Louise 2003:1225-1255.
31. Neffen H, Fritscher C, Cuevas Schacht F, Levy G, Chiarella P, Soriano JB, Mechali D. Asthma control in Latin America: the Asthma Insights and Reality in Latin America (AIRLA) survey. Pev Panam Salud Publica 2005;17(3):191-7.
32. Holgate ST. Genetic and environmental interaction in allergy and asthma. J Allergy Clin Immunol 1999;104(6):1139–1146
33. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989;299(6710): 1259–1260
34. In KH, Asano K, Beier D, Grobholz J, Finn PW, Silverman EK, et al. Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J Clin Invest 1997;99(5):1130–1137
35. Barnes KC, Marsh DG. The genetics and complexity of allergy and asthma. Immunol Today 1998;19:325–332
36. Beuther DA, Weiss ST, Sutherland ER. Obesity and asthma. Am J Respir Crit Care Med 2006;174(2):112–119.
37. Bakırtaş A, Demirsoy MS, Bideci A, Cinaz P. 7-16 yaş çocuklarda obezite ve alerjik solunum yolu hastalığı ilişkisi. Tür. Çocuk Hast. Dergisi 2007; Cilt 1. Sayı 1. 38. Sears MR, Burrows B, Flannery EM, Herbison GP, Holdaway MD. Atopy in childhood. Gender and allergen related risks for development of hay fever and asthma. Clin Exp Allergy 1993;23:941–948
39. Mygind N, Dahl R, Pederson S, Pedersen KT. Allergens: Characteristics and determination. Second Edition Blackwell Science Limited in Essential Allergy 1996;81–89
40. Toraks Dergisi, Astım ve Atopi Gelişiminde Hijyen Hipotezi, 2003;4(3):269–278 41. Sporik R, Holgate ST, Platts-Mills TA, Cogswell JJ. Exposure to house-dust mite allergen and the development of asthma in childhood. A prospective study. N Engl J Med 1990;323(8):502–507
42. Peat JK, Tovey E, Toelle BG, Haby MM, Gray EJ, Mahmic A, et al. House dust mite allergens. A major risk factor for childhood asthma in Australia. Am. J. Respir Crit Care Med. 1996;153(1):141–146
43. Gern JE, Busse WW. Relationship of viral infections to wheezing illnesses and asthma. Nat Rev Immunol 2002;2(2):132–138
44. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M,Taussig LM, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999;354(9178):541–545
45. Shaheen SO, Aaby P, Hall AJ, Barker DJ, Heyes CB, Shiell AW, et al. Measles and atopy in Guinea-Bissau. Lancet 1996;347(9018):1792–1796
46. Illi S, von Mutius E, Lau S, Bergmann R, Niggemann B, Sommerfeld C, et al. Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study. BMJ 2001;322(7283):390–395
47. Chaudhuri R, Livingston E, McMahon AD, Thomson L, Borland W, Thomson NC. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 2003;168(11):1308–1311
48. Dezateux C, Stocks J, Dundas I, Fletcher ME. Impaired airway function and wheezing in infancy: the influence of maternal smoking and a genetic predisposition to asthma. Am J Respir Crit Care Med 1999;159(2):403–410
49. Anto JM, Soriano JB, Sunyer J, Rodrigo MJ, Morell F, Roca J, et al. Long term outcome of soybean epidemic asthma after an allergen reduction intervention. Thorax 1999;54(8):670–674
50. Marks GB, Colquhoun JR, Girgis ST, Koski MH, Treloar AB, Hansen P, et al. Thunderstorm outflows preceding epidemics of asthma during spring and summer. Thorax 2001;56(6):468–471
51. Friedman NJ, Zeiger RS. The role of breast-feeding in the development of allergies and asthma. J Allergy Clin Immunol 2005;115(6):1238–1248
52. Grulee CG, Sanford HN. The influence of breast and artificial feeding on infantile egzema. J. Pediatr 1936;9:223-225
53. Sastre J, Vandenplas O, Park HS. Pathogenesis of occupational asthma. Eur Respir J 2003;22(2):364–373
54. Cohn, L., Elias, J. A., Chupp, G. L. Asthma: Mechanisms Of Disease Persistence And Progression, Annu Rev Immunol. 2004;22:789- 815.
55. Pedersen, S., O'Byrne, P. A. Comparison Of The Efficacy And Safety Of Inhaled Corticosteroids In Asthma. Allergy. 1997;52(39):1-34.
56. Amin, K. Lúdvíksdóttir, D., Janson, C., Nettelbladt, O., Björnsson, E., Romans, G. M., Boman, G., Sevéus, L., Venge, P. Inflammation And Structural Changes In The Airways Of Patients With Atopic And Non-Atopic Asthma. Am J Respir Crit Care Med. 2000;162:2295-2301.
57. Baraldi, E., Carraro, S., Alinovi, R., Pesci, A., Ghiro, L., Bodini, A., Piacentini, G., Zacchello, F., Zanconato, S. Cysteinyl Leukotrienes And 8-Isoprostane In Exhaled Breath Condensate Of Children With Asthma Exacerbations. Thorax. 2003;58:505-509.
58. Djukanovic, R. Airway Inflammation In Asthma And Its Consequences: Implications For Treatment In Children And Adults, J Allergy Clin Immunol. 2002;109(6):539-548.
59. Cairns, J. A., Walls, A. F. Mast Cell Tryptase Stimulates The Synthesis Of The Type 1 Collagen In Human Lung Fibroblasts. J Clin Invest. 1997;99:1313-1321. 60. Louis, R., Lau, L. C., Bron, A. O., Roldaan, A. C., Radermecker, M., Djukanovic, R. The Relationship Between Airways Inflammation And Asthma Severity, Am J Respir Crit Care Med. 2000;161:9-16.
61. Louis, M. B. Astım, Çocuk Göğüs Hastalıkları. (N. Güler, Çev). 95-115, 2007. 62. Sampson, A. P. Eosinophils: Provokers Or Bystanders In Asthma? Clin Exp Allergy Rev. 2001;1:73-76.
63. Hall, G., Houghton, C. G., Rahbek, J. U., Lamb, J. R., Jarman, E. R. Suppression Of Allergen Reactive Th2 Mediated Responses And Pulmonary Eosinophilia By Intranasal Administration Of An Immunodominant Peptide Is Linked To IL-10 Production. Vaccine. 2003;21:549–561.
64. Kuipers, H., Lambrecht, B. N. The Interplay Of Dendritic Cells, Th2 Cells And Regulatory T Cells In Asthma, Curr Opin Immunol. 2004;16(6):702-708.
65. Peters-Golden, M. The Alveolar Macrophage: The Forgotten Cell In Asthma, Am J Respir Cell Mol Biol. 2004;31(1):3-7.
66. Ramesh, G., Jindal, S. K., Ganguly, N. K., Dhawan, V. Increased Nitric Oxide Production By Neutrophils In Broncial Asthma. Eur Respir J. 2001;17:868-871. 67. Guo, F. H., Comhair, S. A. A., Zheng, S., Dweik, R. A., Eissa, N. T., Thomassen, M. J., Calhoun, W., Erzurum, S. C. Molecular Mechanisms Of Increased Nitric Oxide (NO) In Asthma: Evidence For Transcriptional And Post-Translational Regulation Of NO Synthesis. J Immunol. 2000;164:5970-5980.
68. Schmidt, L. M., Belvisi, M. G., Bode, K. A., Bauer, J., Schmidt, C., Suchy, M. T., Tsikas, D., Scheuerer, J., Lasitschka, F., Gröne, H. J., Dalpke, A. H. Bronchial Epithelial Cell-Derived Prostaglandin E2 Dampens the Reactivity of Dendritic Cells. J Immunol. 2011;43:23-26.
69. Chung, K. F. Airway Smooth Muscle Cells: Contributing To And Regulating Airway Mucosal Inflammation? Eur Respir J. 2000;15(5):961-968.
70. Groneberg, D. A., Quarcoo, D., Frossard, N., Fischer, A. Neurogenic Mechanisms In Bronchial Inflammatory Diseases, Allergy. 2004;59(11):1139-1152. 71. Miller, A. L., Lukacs, N. W. Chemokine Receptors: Understanding Their Role In Asthmatic Disease, Immunol Allergy Clin North Am. 2004;24(4):667-683.
72. Calder, P. C., Grimble, R. F. Polyunsaturated Fatty Acids, Inflammation And Immunity. Eur J Clin Nutr 2002;56(3):14-19.
73. Leff, A. R. Regulation Of Leukotrienes In The Management Of Asthma: Biology And Clinical Therapy. Annu Rev Med. 2001;52:1-14.
74. Antoniu, S. A. Pitrakinra, Adual IL-4/IL-13 Antagonist For The Potential Treatment Of Asthma And Eczema. Curr Opin Investig Drugs. 2010;11(11):1286- 1294.
75. Corrigan, C. J., Wang, W., Meng, Q. T-helper Cell Type 2 (Th2) Memory T Cell- potentiating Cytokine IL-25 Has The Potential To Promote Angiogenesis In Asthma. Proc Nati Acad Sci USA. 2011;32(4):75-77.
77. Ashutosh, K. Nitric Oxide And Asthma: A Review. Curr Opin Pulm Med. 2000;6:21-25.
78. Bhagat, K., Vallance, P. Nitric Oxide 9 Years On. J R Soc Med. 1996;89:667- 673.
79. Vignola, A. M., Mirabella, F., Costanzo, G., Di Giorgi, R., Gjomarkaj, M., Bellia, V. Airway Remodeling In Asthma. Chest. 2003;123(3):417-422.
80. Payne, D. N., Adcock, I. M., Wilson, N. M., Oates, T., Scallan, M. Bush, A. Relationship Between Exhaled Nitric Oxide And Mucosal Eosinophilic Inflammation In Children With Difficult Asthma, After Treatment With Oral Prednisolone. Am J Respir Crit Care Med. 2001;164:1376-1381.
81. Türktaş, H., Türktaş, İ. Asthma. Ankara: Bozkır Matbaacılık, 1998.
82. Alving, K., Weitzberg, E., Lundberg, J. M. Increased Amount Of Nitric Oxide In Exhaled Air Of Asthmatics. Eur Respir J. 1993;6:1368-1370.
83. Bengtsson, A., Lundberg, M., Avila-Carino, J., Jacobsson, G., Holmgren, A., Scheynius, A. Thiols Decrease Cytokine Levels And Down-Regulate The Expression Of CD30 On Human Allergen-Specific T Helper (Th) 0 And Th2 Cells. Clin. Exp. Imunol. 2001;123(3):350-360.
84. Gosens, R., Stelmack, G. L., Dueck, G., McNeill, K. D., Yamasaki, A., Gerthoffer, W. T., Unruh, H., Gounni, A. S., Zaagsma, J., Halayko, A. J. Role Of Caveolin-1 In p42/p44 MAP Kinase Activation And Proliferation Of Human Airway Smooth Muscle. Am J Physiol Lung Cell Mol Physiol. 2006;291(3):523-534.
85. Hirota, J. A., Ask, K., Farkas, L., Smith, J. A., Ellis, R., Rodriguez-Lecompte, J. C., Kolb, M., Inman, M. D. In Vivo Role of Platelet Derived Growth Factor-BB in Airway Smooth Muscle Proliferation in Mouse Lung. Am J Respir Cell Mol Biol. 2011;21:69-74.
86. Cui, M., Chen, S., Qiu, C., Tao, W., Wu, F., Tao, Y. Relationship Between Airway Remodeling And Inflammatory Mediators And Cytokines In Sputum In Patients With Bronchial Asthma. Zhonghua Jie He He Hu Xi Za Zhi. 2002; 25(6):344-346.
87. Evans, C. M., Kim, K., Tuvim, M. J., Dickey, B. F. Mucus Hypersecretion In Asthma: Causes And Effects. Curr Opin Pulm Med. 2009;15 (1):4-11.
88. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O'Byrne P, Pedersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ. Global strategy for asthma management and prevention, Global Initiative for Asthma, Eur Respir J. 2008;31(1):143-78.
89. Pellegrino R., Viegi G., Brusasco V., Crapo R.O., Burgos F., Casaburi R. Interpretative strategies for lung function tests, Eur Respir J, 2005;26(5):948-968 90. Official statement of the European Respiratory Society. Standardized lung function testing, Eur Respir J Suppl. 1993;16:1-100
91. Eid N., Yandell B., Howell L., Eddy M., Sheikh S. Can peak expiratory flow predict airflow obstruction in children with asthma? Pediatrics 2000;105(2):354-358 92. Pizzichini M.M., Popov T.A., Efthimiadis A., Hussack P., Evans S., Pizzichini E. Spontaneous and induced sputum to measure indices of airway inflammation in asthma, Am J Respir Crit Care Med. 1996;154(1):866-869
93. Kharitonov S., Alving K., Barnes P.J. Exhaled and nasal nitric oxide measurements: recommendations, The European Respiratory Society Task Force, Eur Respir J. 1997;10(7):1683-1693
94. Green R.H., Brightling C.E., McKenna S., Hargadon B., Parker D., Bradding P. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial, Lancet 2002;360(9347):1715-1721
95. Şekerel BE. Türkiye ulusal astım tanı ve tedavi rehberi: Pediatrik hastada uzun 96. Kelly HW. The assessement of childhood asthma. Pediatr Clin N Am 2003;50:593-608.
97. Hanley ME, Welsh CH. Current, Göğüs Hastalıkları Güncel Tanı ve Tedavi. Çeviri editörü: Uçan ES. Güneş Kitabevi Öncü Basımevi 2005;39-45:67-81.
98. Pedersen S, O'Byrne P. A comparison of the efficacy and safety of inhaled corticosteroids in asthma. Allergy. 1997;52(39 Suppl):1-34.
99. Guilbert TW, Morgan WJ, Zeiger RS, Mauger DT, Boehmer SJ, Szefler SJ et al. Long term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006;354(19):1985-97.
100. Pedersen S. Do inhaled corticosteroids inhibit growth in children? Am J Respir Crit Care Med 2001;164(4):521-35.
101. Kemp JP, Osur S, Shrewsbury SB, Herje NE, Duke SP, Harding SM, et al. Potential effects of fluticasone proprionate on bone mineral density in patients with asthma: a 2-year randomized, double-blind, placebo-controlled trial. Mayo Clin Proc 2004;79(4):458-66.
102. Randell TL, Donaghue KC, Ambler GR, Cowell CT, Fitzgerald DA, van Asperen PP. Safety of the newer inhaled corticosteroids in childhood asthma. Paediatr Drugs 2003;5(7):481-504.
103. Shapiro GG. Childhood asthma: Update. Pediatrics in review 1992;11:403- 411. 104. Brenner M, Berkowitz R, Marshall N, Strunk RC. Need for theophylline in severe steroid-requiring asthmatics. Clin Allergy. 1988;18(2):143-50.
105. Simons FE, Villa JR, Lee BW, Teper AM, Lyttle B, Aristizabal G, Laessig W, Schuster A, Perez-Frias J, Sekerel BE, Menten J, Leff JA. Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study. J Pediatr 2001;138(5):694-8.
106. Bengtsson B, Fagerstrom PO. Extrapulmonary effects of terbutaline during prolonged administration. Clin Pharmacol Ther 1982;31(6):726-32.
107. World Health Organization. European Charter On Counteracting Obesity. WHO European Ministerial Conference On Counteracting Obesity Conference Report. Genova: WHO, 2007.
108. Köksal, E., Küçükerdönmez, Ö. Şişmanlığı Saptamada Güncel Yaklaşımlar. A. Baysal, M. Baş (Ed.). Yetişkinlerde Ağırlık Yönetimi. Türkiye Diyetisyenler Derneği Yayını, s. 35-70, Ankara: Ekspres Baskı A.Ş. 2008.
109. Onat, A. Türkiye'de Obezitenin Kardiyovasküler Hastalıklara Etkisi. Türk Kardiyoloji Dergisi 2003;31(5):279-289.
110. Han, T. S., Van Leer, E. M., Seidell, J. C., Lean, M. E. Waist Circumference As A Screening Tool For Cardiovascular Risk Factors: Evaluation Of Receiver Operating Characteristics (ROC). Obes Res. 1996;4(6):533-547.
111. Arslan, M., Başkal, N., Çorakçı, A. ve diğerleri. Ulusal Obezite Rehberi. Türkiye Endokrinoloji ve Metabolizma Derneği Yayını, 1999.
112. Akram, D. S., Astrup, A. V., Atinmo, T. ve diğerleri. World Health Organization Obesity: Preventing And Managing The Global Epidemic. WHO Technical Report (Rapor No: 894). Geneva: WHO, 2005.
113. Neyzi, O., Furman, A., Bundak, R., Günoz, H., Darendeliler, F., Bas, F. Growth References For Turkish Children Aged 6 To 18 Years. Acta Pediatr 2006;95:1635- 1641
114. Sancak, R., Dündar, C., Totan, M., Çakır, M., Sunter, T., Küçüködük Ş. Ortaokul Ve Lise Öğrencilerinde Obezite Prevalansı Ve Predispozan Faktörler. Ondokuz Mayıs Üniversitesi Tıp Dergisi 1999;16:19-24.
115. Giammattei, J., Blix, G., Marshak, H. H., Wollitzer, A. O., Pettitt, D. J. Television Watching And Soft Drink Consumption: Associations With Obesity In 11- To 13-Year-Old Schoolchildren. Arch Pediatr Adolesc Med. 2003;157:882-886. 116. World Health Organization. The Challenge Of Obesity In The WHO European Region And The Strategies For Response, F. Branca, H. Nikogosian, T. Lobstein (Ed.). Denmark: WHO, 2007.
117. Sağlık Bakanlığı. Türkiye Hastalık Yükü Çalışması 2004, Ankara: Refik Saydam Hıfzıssıhha Merkezi Başkanlığı. Hıfzıssıhha Mektebi Müdürlüğü, 2006. 118. Von Mutius, E., Schwartz, J., Neas, L. M., Dockery, D., Weiss, S. T. Relation Of Body Mass Index To Asthma And Atopy In Children: The National Health And Nutrition Examination Study III. Thorax. 2001;56:835–838.
119. Gold, D. R., Damokosh, A. I., Dockery, D. W., Berkey C. S. Body-Mass Index As A Predictor Of Incident Asthma In A Prospective Cohort Of Children. Pediatr Pulmonol. 2003;36:514–521.
120. Schachter, L. M., Peat, J. K., Salome, C. M. Asthma And Atopy In Overweight Children. Thorax 2003; 58:1031–1035. 121. Chinn, S., Rona, R. J. Can The Increase In Body Mass Index Explain The Rising Trend In Asthma In Children? Thorax 2001;56:845–850.
122. To, T., Vydykhan, T. N., Dell, S., Tassoudji, M., Harris, J. K. Is Obesity Associated With Asthma In Young Children? J Pediatr. 2004;144:162–168.
123. Maniscalco, M., Zedda, A., Faraone, S ve diğerleri. Weight Loss And Asthma Control In Severely Obese Asthmatic Females. Respir Med. 2008;102:102-108. 124. Malmberg, L. P., Pelkonen, A. S., Mattila, P. S, Hammaren-Malmi S., Makela M. J. Exhaled Nitric Oxide And Exercise-Induced Bronchoconstriction In Young Wheezy Children - Interactions With Atopy. Pediatr Allergy Immunol. 2009;20(7):
125. Gustafsson, L. E., Leone, A. M., Persson, M. G., Wiklund, N. P., Moncada, S. Endogenous Nitric Oxide Is Present In The Exhaled Air Of Rabbits, Guinea Pigs And Humans. Biochem Biophys Res Commun. 1991;181:852-857.
126. Alving, K., Janson, C., Nordvall, L. Performance Of A New Hand-Held Device For Exhaled Nitric Oxide Measurement In Adults And Children. Respir Res, 7-67, 2006.
127. Warke, T. J., Fitch, P. S.,Brown, V. Exhaled Nitric Oxide Corraletes With Airway Eosinophils In Childhood Asthma. Thorax 2002;57:383-387.
128. American Thoracic Society/European Respiratory Society. ATS/ERS Recommendations For Standardized Procedures For The Online And Offline Measurements Of Exhaled Lower Respiratory Nitric Oxide And Nasal Nitric Oxide. Am J Respir Crit Care Med. 2005;171:912-930.
129. Bayram, H. Hava Yolu İnflamasyonun Değerlendirilmesi. Göğüs Hastalıklarında Tanı Yöntemleri-2. (s.137-174). İstanbul: Turgut Yayıncılık, 2003. 130. Tsujino, I., Nishimura, M,, Kamachi, A. ve diğerleri. Exhaled Nitricoxide-is It Really A Good Marker Of Airway Inflammationin Bronchial Asthma? Respiration 2000;67:645-651.
131. Olin, A. C., Rosengren, A., Thelle, D. S. ve diğerleri. Height, Age, And Atopy Are Associated With Fraction Of Exhaled Nitric Oxide In A Large Adult General Population Sample. Chest. 2006;130:1319-1325.
132. Tsang, K. W., Ip S. K., Leung R. ve diğerleri. Exhaled Nitric Oxide: The Effects Of Age, Gender And Body Size. Lung. 2001;179:83-91.
133. Türk toraks derneği astım ve alerji çalışma grubu. Tanım ve genel bakış. Astım Tanı ve Tedavi rehberi. 2009 (ek:10);6-9
134. Hancox RJ, Milne BJ, Poulton R, et al. Sex differences in the relation between body mass index and asthma and atopy in a birth cohort. Am J Respir Crit Care Med 2005;171:440-5.
135. Shore SA. Obesity and asthma: lessons from animal models. J Appl Physiol 2007;102(2):516-28.
136. Thomsen SF, Ulrik CS, Kyvik KO, Sorensen TI, Posthuma D, Skadhauge LR ve ark. Association between obesity and asthma in a twin cohort. Allergy 2007;62(10): 1199-204.
137. Abramson NW, Wamboldt FS, Mansell AL, Carter R, Federico MJ, Wamboldt MZ. Frequency and correlates of overweight status in adolescent asthma. J Asthma 2008;45(2):135-9.
138. Chen Y, Rennie D, Cormier Y, Dosman J. Sex specificity of asthma associated with objectively measured body mass index and waist circumference. Chest 2005; 128:3048-54.
139. Gale SM, Castracane VD, Mantzoros CS. Energy homeostasis, obesity and eating disorders: recent advances in endocrinology. J Nutr 2004;134(2):295-8.
140. Pitt HA. Hepato-pancreato-biliary fat: the good, the bad and the ugly. HPB (Oxford) 2007;9(2):92-97.
141. Yumuk VD. Prevalence of obesity in Turkey. Obes Rev 2000;6(1):9-10.
142. Hatemi H, Yumuk VD, Turan N, Arık N. Prevalence of overweight and obesity in Turkey. Metab Syndr Relat Disord 2003;1(4):285-90.
143. Öner N, Vatansever U, Sarı A, Ekuklu E, Güzel A, Karasalioğlu S ve ark. Prevalence of underweight, overweight and obesity in Turkish adolescents. Swiss Med Wkly 2004;134(35-36):529-33.
144. Şimşek E, Akpınar S, Bahçebaşı T, Şenses DA, Kocabay K. The prevalence of overweight and obese chidren aged 6-17 years in the West Black Sea region of Turkey. Int J Clin Pract 2008;62(7):1033-8.
145. Türkkahraman D, Bircan I, Tosun O, Saka O. Prevalence and risk factors of obesity in school children in Antalya, Turkey. Saudi Med J 2006;27(7):1028-33. 146. Ones U, Akcay A, Tamay Z, Guler N, Zincir M. Rising trend of asthma prevalence among Turkish schoolchildren (ISAAC phases I and III). Allergy 2006; 61:1448-53.
147. Önes Ü., Sapan N., Somer A., Disci R., et al. Prevalence of childhood asthma in Istanbul, Turkey. Allergy 1997;52:570-575.
148. Akcakaya N., Kulak K., Hassanzadeh A., Camcioğlu Y., Cokugras H., Prevelence of bronchial asthma and allergic rhinitis in Istanbul school children. Eur J Epidemiol 2000;16(8):693-699
149. Bayram I, Güneser-Kendirli S, Yılmaz M, Altıntas D, Alparslan N, Bingöl- Karakoç G.The prevalance of asthma and allergic disease in children of school age in
150. Tomaç N., Demirel F., Acun C., Ayoğlu F. Prevalence and risk factors for childhood asthma in Zonguldak, Turkey. Allergy Asthma Proc 2005;26(5):397-402 151. Ece A., Ceylan A., Saraclar Y., Saka G., Gurkan F., Haspolat K. Prevalence of asthma and other allergic disorders among schoolchildren in Diyarbakir, Turkey.Turk J Pediatr 2001;43(4):286-292
152. Uyan AP, Gozukara A, Yesildal N: Prevalence of asthma and allergic disorder among children in Duzce, Turkey: ISAAC Phase One.The Internet Journal of Epidemiology 2003;1:1.
153. Jacobs JH, Spaan S, van Rooy GB, Meliefste C, Zaat VA, Rooyackers JM et al. Exposure to trichloramine and respiratory symptoms in indoor swimming pool workers. Eur Respir J 2007;29:690–698
154. Horváth I, Hunt J, Barnes PJ, et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005;26:523-48.